The Acute Effect of a Low Dosage of Pramipexole on Severe Idiopathic Restless Legs Syndrome: An Open-Label Trial
Authors:
- Giovanni MerlinoGMGiovanni Merlino
- Pierluigi DolsoPDPierluigi Dolso
- Roberto CanesinRCRoberto Canesin
- Iacopo CancelliICIacopo Cancelli
- Mariarosaria ValenteMVMariarosaria Valente
- Gian Luigi GigliGGGian Luigi Gigli
- 1 January 2006
- journal article
- clinical trial
- Published by S. Karger AG in Neuropsychobiology
- Vol. 54 (3) , 195-200
Abstract
Background: Pramipexole is a D3 dopaminergic agonist that has shown a major effect on both sensory and motor manifestations of restless legs syndrome (RLS) in long-term trials. No data regarding the acute effect of low doses of pramipexole have been reported. Objective: To evaluate the acute effect of a low dosage of pramipexole (0.125 mg) on sensory symptoms and motor signs of RLS and on the macro- and microstructure of sleep. Methods: We initially recruited 13 patients affected by severe idiopathic RLS and included 10 of them in our study. For 2 consecutive nights the selected patients were evaluated. Pramipexole 0.125 mg was administered before the second night at 9:00 p.m. A visual analog scale was used to assess the sensory symptoms of RLS. The motor manifestations of RLS and the architecture of sleep were analyzed by polysomnography. Results: After the acute administration of pramipexole, we observed a significant improvement of the sensory symptoms and motor signs of RLS. Several sleep macrostructure and microstructure parameters improved as well. Conclusions: Our results suggest that low doses of pramipexole are effective in reducing sensory symptoms and motor signs of RLS, even after the first administration.Keywords
This publication has 19 references indexed in Scilit:
- Efficacy and safety of pramipexole in restless legs syndromeNeurology, 2006
- Restless legs syndromeNeurology, 2006
- The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG)Sleep Medicine, 2006
- Low-Dose Pramipexole in the Management of Restless Legs SyndromeNeuropsychobiology, 2004
- Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndromeSleep Medicine, 2003
- Restless legs syndrome: diagnostic criteria, special considerations, and epidemiologySleep Medicine, 2003
- Atlas, rules, and recording techniques for the scoring of cyclic alternating pattern (CAP) in human sleepSleep Medicine, 2001
- Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteriaMovement Disorders, 1997
- The Cyclic Alternating Pattern Plays a Gate-Control on Periodic Limb Movements During Non-Rapid Eye Movement SleepJournal Of Clinical Neurophysiology, 1996
- Modifications of sleep structure induced by increasing levels of acoustic perturbation in normal subjectsElectroencephalography and Clinical Neurophysiology, 1990